Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 201

The DOI matches its Crossref record.

Hepatitis B Immune Globulin for Accidental Exposures among Medical Personnel: Final Report of a Multicenter Controlled Trial

Grady, G. F., Lee, V. A., Prince, A. M., Gitnick, G. L., Fawaz, K. A., Vyas, G. N., Levitt, M. D., Senior, J. R., Galambos, J. T., Bynum, T. E., Singleton, J. W., Clowdus, B. F., Akdamar, K., Aach, R. D., Winkelman, E. I., Schiff, G. M., Hersh, T. · 1978 · Journal of Infectious Diseases

Abstract

Medical personnel accidentally exposed to blood from patients who had acute hepatitis or carried hepatitis B surface antigen (HBsAg) were assigned randomly to receive two injections one month apart of immune serum globulin containing a high titer of antibody to HBsAg (anti-HBs) (269 subjects), an intermediate titer (223 subjects), or a normal titer (265 subjects). Four months after exposure nearly 7% of recipients of normal-titer globulin or intermediate-titer globulin had developed hepatitis B, whereas no cases had appeared among recipients of high-titer globulin (P < 0.01). However, an excess of late-onset cases in recipients of high-titer globulin nullified initial evidence of protection; at follow-up at nine months, the cumulative incidence of hepatitis B had reached 8.7%, 7.3%, and 7.2%, respectively, in the three groups (P > 0.30). Intercurrent infection was estimated to have accounted for only 20% of late-onset cases; 80% were thought to reflect an effect of high-titer globulin which was sufficient to delay onset but insufficient to reduce clinical severity. Many of these cases emerged in the presence of anti-HBs residual from administration of hightiter globulin, whereas no cases occurred in individuals who already possessed minimal amounts of anti-HBs at the time of exposure. The high-titer globulin was found to contain fragmented anti-HBs which may have interfered with the neutralizing activity of the large amount of unfragmented anti-HBs also present in the high-titer globulin. In any event, the lack of significant protection in the current trial means that a decision to use high-titer globulin as postexposure prophylaxis will have to rest upon the evidence of protection that has been obtained by others.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/138.5.625

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 201

Metadata

Authors
Grady, G. F., Lee, V. A., Prince, A. M., Gitnick, G. L., Fawaz, K. A., Vyas, G. N., Levitt, M. D., Senior, J. R., Galambos, J. T., Bynum, T. E., Singleton, J. W., Clowdus, B. F., Akdamar, K., Aach, R. D., Winkelman, E. I., Schiff, G. M., & Hersh, T.
Venue
Journal of Infectious Diseases
Published
1978-11-01
Volume
138
Issue
5
Pages
625-638
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2004503654
Cited by
201
References
0
FWCI
9.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatitis B Immune Globulin for Accidental Exposures among Medical Personnel: Final Report of a Multicenter Controlled Trial. https://app.cochat.ai/papers/10.1093/infdis/138.5.625
The paper
Grady, G. F., Lee, V. A., Prince, A. M., Gitnick, G. L., Fawaz, K. A., Vyas, G. N., Levitt, M. D., Senior, J. R., Galambos, J. T., Bynum, T. E., Singleton, J. W., Clowdus, B. F., Akdamar, K., Aach, R. D., Winkelman, E. I., Schiff, G. M., & Hersh, T. (1978). Hepatitis B Immune Globulin for Accidental Exposures among Medical Personnel: Final Report of a Multicenter Controlled Trial. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/138.5.625

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.